➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
McKesson
Boehringer Ingelheim
Merck
Mallinckrodt

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: GADOBENATE DIMEGLUMINE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

GADOBENATE DIMEGLUMINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357 NDA BRACCO DIAGNOSTICS INC 0270-5164-12 5 VIAL, SINGLE-DOSE in 1 BOX (0270-5164-12) > 5 mL in 1 VIAL, SINGLE-DOSE
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357 NDA BRACCO DIAGNOSTICS INC 0270-5164-13 5 VIAL, SINGLE-DOSE in 1 BOX (0270-5164-13) > 10 mL in 1 VIAL, SINGLE-DOSE
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357 NDA BRACCO DIAGNOSTICS INC 0270-5164-14 5 VIAL, SINGLE-DOSE in 1 BOX (0270-5164-14) > 15 mL in 1 VIAL, SINGLE-DOSE
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357 NDA BRACCO DIAGNOSTICS INC 0270-5164-15 5 VIAL, SINGLE-DOSE in 1 BOX (0270-5164-15) > 20 mL in 1 VIAL, SINGLE-DOSE
Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021358 NDA BRACCO DIAGNOSTICS INC 0270-5264-16 5 BOTTLE, GLASS in 1 BOX (0270-5264-16) > 50 mL in 1 BOTTLE, GLASS
Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021358 NDA BRACCO DIAGNOSTICS INC 0270-5264-17 5 BOTTLE, GLASS in 1 BOX (0270-5264-17) > 100 mL in 1 BOTTLE, GLASS
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Merck
Express Scripts
AstraZeneca
McKinsey